The DOI matches its Crossref record.
Hypertriglyceridemic Waist: A Marker of the Atherogenic Metabolic Triad (Hyperinsulinemia; Hyperapolipoprotein B; Small, Dense LDL) in Men?
Abstract
Background —The present study tested the hypothesis that simple variables, such as waist circumference and fasting plasma triglyceride (TG) concentrations, could be used as screening tools for the identification of men characterized by a metabolic triad of nontraditional risk factors (elevated insulin and apolipoprotein [apo] B and small, dense LDL particles). Methods and Results —Results of the metabolic study (study 1) conducted on 185 healthy men indicate that a large proportion (>80%) of men with waist circumference values ≥90 cm and with elevated TG levels (≥2.0 mmol/L) were characterized by the atherogenic metabolic triad. Validation of the model in an angiographic study (study 2) on a sample of 287 men with and without coronary artery disease (CAD) revealed that only men with both elevated waist and TG levels were at increased risk of CAD (odds ratio of 3.6, P <0.03) compared with men with low waist and TG levels. Conclusions —It is suggested that the simultaneous measurement and interpretation of waist circumference and fasting TG could be used as inexpensive screening tools to identify men characterized by the atherogenic metabolic triad (hyperinsulinemia, elevated apo B, small, dense LDL) and at high risk for CAD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Adding biochemical markers, such as plasma triglyceride levels, to the measurement of waist circumference—a phenotype described as hypertriglyceridaemic waist—has been suggested as a useful method for identification of individuals with excess visceral adipose tissue and ectopic fat.51”
From Definition and diagnostic criteria of clinical obesity (2025) · cites this paper as [51]
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 28
- 10.1073/pnas.77.1.604 · DOI
- 10.1161/circ.94.3.273 · DOI
- 10.1136/hrt.71.3.293 · DOI
- 10.1056/NEJM199604113341504 · DOI · Paper page
- 10.1161/atv91.12.2.1543692 · DOI
- 10.1161/circ.95.1.69 · DOI
- 10.1001/jama.279.24.1955 · DOI
- 10.2337/diab.41.7.826 · DOI
- 10.1016/0002-9149(94)90676-9 · DOI
- 10.2337/diacare.19.6.629 · DOI · Paper page
- 10.1093/clinchem/28.10.2077 · DOI
- 10.1093/clinchem/20.4.470 · DOI
- 10.1172/JCI103182 · DOI
- 10.1016/0009-8981(60)90075-9 · DOI
- 10.1016/0003-2697(66)90246-6 · DOI
- 10.1016/0026-0495(87)90183-1 · DOI
- 10.1210/jcem-33-5-732 · DOI
- Standardization of anthropometric measurements. In: Lohman T Roche A Martorel R eds. The Airlie (VA) Consensus Conference. Champaign Ill: Human Kinetics; 1988:39–80.
- 10.1079/BJN19890104 · DOI
- 10.1016/S0002-9149(98)00328-2 · DOI
- 10.1161/circ.97.9.871 · DOI
- 10.1016/0009-8981(87)90188-4 · DOI
- 10.1093/clinchem/28.6.1379 · DOI
- 10.1093/clinchem/18.6.499 · DOI · Paper page
- 10.1161/atv91.12.11.1420088 · DOI
- 10.1161/01.CIR.85.1.37 · DOI · Paper page
- 10.1079/NRR19930010 · DOI
- 10.1016/S0140-6736(94)90814-1 · DOI
Cited by
Sorted by citations
Items 701–800 of 819
Faurholt-Jepsen, D., Friis, H., Mwaniki, D., Boit, M., Kaduka, L., Tetens, I., & Christensen, D. (2021) · PLoS ONE · doi:10.1371/journal.pone.0247600 · Cited by 2
HYPERTRIGLICERIDEMIC WAIST, PHYSICAL ACTIVITY AND CARDIOVASCULAR RISK FACTORS IN SCHOOLCHILDREN
Guilherme, F. R., Fiorillo, R. G., dos Santos, S. R., Graça, Á., Fonseca, H. S., Nascimento, M., & Rinaldi, W. (2020) · bioRxiv · doi:10.1101/2020.06.05.136101 · Cited by 2
Vitamin D is associated with the hypertriglyceridemic waist phenotype in Brazilian children.
Milagres, L. C., Filgueiras, M. D. S., Rocha, N. P., Juvanhol, L. L., Franceschini, S. C. C., & de Novaes, J. F. (2020) · Journal of public health · doi:10.1093/pubmed/fdaa041 · Cited by 2
Rhee, E. (2017) · Endocrinology and Metabolism · doi:10.3803/enm.2017.32.3.396 · Cited by 2
Kelishadi, R., Jamshidi, F., Qorbani, M., Motlagh, M., Heshmat, R., Ardalan, G., & Hovsepian, S. (2016) · doi:10.1016/j.jpedp.2016.06.014 · Cited by 2
Obesity and Lifestyle Modification
Blomeier, H., & Stone, N. J. (2013) · CRC Press eBooks · doi:10.3109/9781420019667-9
Metabolic syndrome in adults: relation with diet and other lifestyle factors
Kataria, I., Chadha, R., & Pathak, R. (2015) · Reviews in Health Care · doi:10.7175/rhc.v6i3.1188 · Cited by 2
“Abdominal obesity [71,76,77], insulin resistance [6,78], along with physical inactivity [71,79], aging [23], hormonal imbalance [80], and atherogenic diet (a diet rich in saturated fat and cholesterol) can exacerbate the risk for developing MetS, and consequently CVD [1].”
BackgroundLipid Peroxidation and Age-Related Neurodegenerative Disorders
Spickett, C., & Forman, H. (2015) · CRC Press eBooks · doi:10.1201/b18138-21 · Cited by 2
If not dieting, how to lose weight? Tips and tricks for a better global and cardiovascular health
Leclerc, J., Bonneville, N., Auclair, A., Bastien, M., Leblanc, M., & Poirier, P. (2015) · Postgraduate medicine · doi:10.1080/00325481.2015.993884 · Cited by 2
“A hypertriglycerides state is known to be linked to elevated WC as well as visceral and ectopic fat deposition [20].”
BackgroundDespres, J., & Clément, K. (2013) · EMC - Endocrinologie - Nutrition · doi:10.1016/s1155-1941(13)56367-0 · Cited by 2
Self-citationTaloyan, M., Saleh-Stattin, N., Johansson, S., Agréus, L., & Wändell, P. (2012) · BMC Research Notes · doi:10.1186/1756-0500-5-474 · Cited by 2
“Hypertriglyceridemic waist (HyperTG waist) is a suggested as a screening tool for identification of metabolic syndrome and based on several studies [24-26].”
BackgroundReducing the risk of macrovascular complications of diabetes: focus on visceral fat
Sam, S., & Mazzone, T. (2011) · Diabetes Management · doi:10.2217/dmt.11.22 · Cited by 2
Pediatric Non-High-Density Lipoprotein Cholesterol, the Metabolic syndrome, and Insulin Resistance
Glueck, C., & Morrison, J. (2010) · Jornal de Pediatria · doi:10.1016/j.jpeds.2010.09.016 · Cited by 2
Metabolic syndrome: More questions than answers?
Spellman, C., & Chemitiganti, R. (2010) · doi:10.7556/jaoa.2010.20017 · Cited by 2
The Quebec Heart Institute: 50 years of excellence in cardiology.
Dagenais, G., Philippon, F., Despres, J., Dumesnil, J., Cartier, P., Bogaty, P., Lemieux, M., & Moisan, A. (2007) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(07)71004-8 · Cited by 2
Self-citationMetabolic syndrome: New research findings
Nugent, A. (2005) · Practice Nursing · doi:10.12968/pnur.2005.16.2.17497 · Cited by 2
Features of the metabolic syndrome and the risk of cardiovascular disease
Lamarche, B., & St‐Pierre, A. (2005) · Biomarkers · doi:10.1080/13547500500216579 · Cited by 1
“It has also been suggested that variations in waist circumference, in combination with plasma TG levels, were very powerful in predicting individuals who are characterized as having the metabolic triad, namely elevated plasma insulin and apolipoprotein B levels as well as small dense LDL particles (Lemieux et al. 2000…”
BackgroundSelf-citationAlexander, C. M., Landsman, P. B., Nag, S. S., Teutsch, S. M., & Haffner, S. M. (2004) · Clinical Research and Regulatory Affairs · doi:10.1081/crp-200049995 · Cited by 2
“They further proposed that waist circumference was the simplest anthropometric measurement to predict visceral fat accumulation (7).”
BackgroundThe athero-thrombotic and inflammatory profile of visceral obesity
Despres, J. (2003) · International Congress Series · doi:10.1016/s0531-5131(03)00143-2 · Cited by 2
Self-citationObesity: the dire consequences of a genetic program for survival?
Sharma, A., & Despres, J. (2001) · Journal of molecular medicine · doi:10.1007/s001090000166 · Cited by 2
Self-citationBirro, R. A. M., Mendonça, H. X. M., Bezerra, O. M. D. P. A., Zandonade, E., & Salaroli, L. B. (2026) · Journal of Human Growth and Development · doi:10.36311/jhgd.v36.18813 · Cited by 1
“Investigations conducted in rural populations have also demonstrated associations between HTGW and increased risk of type 2 diabetes, stroke and other cardiovascular outcomes, suggesting that the phenotype represents an early marker of vascular risk 2,3 .”
Müller, M. J., Heymsfield, S. B., & Bosy‐Westphal, A. (2026) · Obesity Facts · doi:10.1159/ofa/adzag006
“The HTGW therefore represents a simple and cost-effective surrogate marker for dysfunctional adipose tissue and for identifying individuals at risk of increased insulin resistance, type 2 diabetes [54, 55], and cardiovascular disease [55, 56].”
Hypertriglyceridemic waist and subclinical atherosclerosis: a systematic review and meta-analysis
Xiong, W. G., Fan, H., You, Y., Yu, Q., Xin, Z., Tang, T. S., Rao, X., Feng, L., Shi, Y., Tong, X., et al. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1660540 · Cited by 1
Rauf, R., Memon, A., Rasheed, S., Iqtdar, R., Aamir, K., Saghir, T., & Kazmi, K. (2025) · Pakistan Heart Journal · doi:10.47144/phj.v58is3.3370 · Cited by 1
Lee, H., Park, H.-S., Jun, S.-I., Jang, H., Hong, Y.-S., Jung-Choi, K., Lee, H. A., & Park, H. (2025) · PLoS ONE · doi:10.1371/journal.pone.0335507 · Cited by 1
“HWP, defined by waist circumference and triglyceride levels, is a predictor of the atherogenic metabolic triad, characterized by hyperinsulinemia, elevated apolipoprotein B, and small Low-Density Lipoprotein (LDL) particles [14–16].”
Linking anthropometric indices with components of metabolic syndrome among Nigerian adolescents
Holdbrooke, S. A., Afolabi, B. M., Onabanjo, O. O., Salau, I. O., & Lucas, O. T. (2025) · Academia Medicine · doi:10.20935/acadmed7492 · Cited by 1
Promotion of Cardiometabolic Health: A Personal Journey
Després, J. (2025) · Current Cardiology Reports · doi:10.1007/s11886-024-02165-9 · Cited by 1
“…that a commonly measured blood lipid marker, triglycerides (TG), could be helpful when combined with waist circumference for the identification of individuals likely to be characterized by visceral obesity, this adiposity phenotype being closely associated with increased circulating TG levels [23].”
Shishira, R., Shashikiran, H. C., Sujatha, K. J., & Shetty, P. (2024) · Advances in Integrative Medicine · doi:10.1016/j.aimed.2024.10.010 · Cited by 2
Impact of excessive abdominal obesity on brain microstructural abnormality in schizophrenia
Yamada, S., Takahashi, S., Keeser, D., Keller-Varady, K., Schneider-Axmann, T., Raabe, F. J., Dechent, P., Wobrock, T., Hasan, A., Schmitt, A., et al. (2024) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2024.111878 · Cited by 1
Najeh, H., Rherissi, B., Dwassy, Y., Belmouden, A., & Chadli, S. (2024) · Roczniki Panstwowego Zakladu Higieny · doi:10.32394/rpzh/190852 · Cited by 1
“Lemieux et al. in 2000 [20] suggested that males displaying atherogenic metabolic traits and facing a heightened risk of coronary heart disease might be detectable through an inexpensive screening approach involving the assessment and analysis of waist circumference and triglyceride levels.”
BackgroundOh, J.-E., Yu, S. R., Yoo, J., & Shin, K. (2024) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s444084 · Cited by 2
Liu, X., Ma, C., Wang, R., Lu, N., Ma, C., Yin, F., & Lu, Q. (2023) · American Journal of Men s Health · doi:10.1177/15579883231170172 · Cited by 1
“Previous studies had reported that HTGW could be used as a simple screening approach to predict diabetes (He et al., 2013; Lemieux et al., 2000; Zhang et al., 2012).”
BackgroundInfluentialLeisure time versus occupational physical activity for cardiometabolic risk.
Neeland, I., & Lavie, C. (2023) · Progress in cardiovascular diseases · doi:10.1016/j.pcad.2023.04.003 · Cited by 1
Xuan, Y., Xi, G., Shen, Y., Wang, S., Gao, P., Tang, D., Xun, Wang, Zhu, F., Lu, L.-Q., et al. (2022) · Annals of Case Reports · doi:10.29011/2574-7754.100970 · Cited by 1
da Silva, D. A. R., de Almeida, L. S., Correa, L. L., Pimentel, R., Gomes, A. T., Travassos, A. G., Viana, A. M., Cerqueira, M. M. B. D. F., de Souza, M. C., de Sousa, A. D., et al. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph191610203 · Cited by 1
Feng, Y., Yang, X., Li, Y., Han, M., Qie, R., Huang, S., Wu, X., Zhang, Y., Wu, Y., Liu, D., et al. (2021) · Primary care diabetes · doi:10.1016/j.pcd.2021.05.005 · Cited by 1
Cabrera-Rode, E., Coronel, A. C. B., de Oca-Somoano, R. M., Rodríguez-Acosta, J., Cubas-Dueñas, I., Arnold-Domínguez, Y., Hernández-Rodríguez, J., & Díaz-Díaz, O. (2020) · Alad · doi:10.24875/alad.20000413 · Cited by 1
Ferreira, J., de Oliveira, R. B. M., Cattafesta, M., & Salaroli, L. (2020) · DEMETRA: Alimentação, Nutrição & Saúde · doi:10.12957/demetra.2020.48609 · Cited by 1
Mayer, O., Seidlerová, J., Bruthans, J., Timoracká, K., Vágovičová, P., Vaněk, J., Wohlfahrt, P., Filipovský, J., & Cífková, R. (2014) · Clinical Lipidology · doi:10.2217/clp.14.49 · Cited by 1
Creation of an Adiposity Index for Children Aged 6–8 Years: The Gateshead Millennium Study
Pearce, M. S., James, P. W., Franco‐Villoria, M., Parkinson, K. N., Jones, A. R., Basterfield, L., Drewett, R. F., Wright, C. M., & Adamson, A. (2013) · BioMed Research International · doi:10.1155/2013/431825 · Cited by 1
Population, M., Aye, M., Jsf, C., & Msa, R. (2013) · doi:10.4172/2167-0943.1000124 · Cited by 1
Choi, S.-H., Shin, S.-W., & Yoo, C. (2012) · doi:10.5762/kais.2012.13.11.5271 · Cited by 1
Obesity and the Metabolic Syndrome
Grandjean, P. W. (2012) · CRC Press eBooks · doi:10.1201/b12085-17 · Cited by 3
Systematic Review on Dietary Intake and Metabolic Syndrome in Children and Adolescents
Nourian, M., Yassin, Z., Taib, M. N. M., Haghighatdoost, F., & Kelishadi, R. (2012) · PARIPEX-INDIAN JOURNAL OF RESEARCH · doi:10.15373/22501991/june2014/50 · Cited by 1
Metabolic syndrome and psychopathology: a possible relationship?
Valentino, S., Benedetta, M., Pandolfo, M. M., & Leotta, S. (2011) · Mediterranean Journal of Nutrition and Metabolism · doi:10.1007/s12349-011-0074-7 · Cited by 1
“It is undoubtedly difficult to distinguish clearly the underlying pathophysiology time, [13–20], although major results have been obtained along this fundamental directive of research.”
Oda, E. (2010) · Ningen dock : official journal of the Japanese Society of Human Dry Dock · doi:10.11320/ningendock.24.1 · Cited by 1
Quel bilan et quel suivi métabolique doit-on faire dans le SAHOS ? Pour quels patients ?
Orvoën-Frija, E. (2009) · Revue de Pneumologie Clinique · doi:10.1016/j.pneumo.2009.07.008 · Cited by 1
Detection of small dense LDL-cholesterol: is it necessary to determine particle size?
Wierzbicki, A. S. (2008) · Future Lipidology · doi:10.2217/17460875.3.1.23 · Cited by 1
Cardiometabolic risk factors and their treatment in patients with Type 2 diabetes
Kumar, S. (2007) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2.3.331
Importancia de la prevención cardiovascular en la diabetes mellitus: un reto pendiente
Pedro-Botet, J. (2006) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/s0214-9168(06)73678-6 · Cited by 1
Lipid management in Type 1 diabetes
Pachaiappan, K. J., Patel, V. B., Morrissey, J., & Gadsby, R. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01833d.x · Cited by 3
Place des glitazones dans de futures recommandations cliniques
Halimi, S. (2005) · Annales d Endocrinologie · doi:10.1016/s0003-4266(05)81734-2 · Cited by 1
“En effet, ce groupe a bien montré le rôle défavorable de la répartition abdominale (viscérale) des dépôts graisseux et d’un profil dyslipidémique athérogène (augmentation du nombre des LDL petites et denses, HDL-cholestérol abaissé, augmentation des triglycérides), conduisant à un profil pro-inflammatoire athéro-throm…”
BackgroundPombo, J. L. H., & Sánchez-Vilar, O. (2004) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0211-3449(04)70146-0 · Cited by 1
Niacin after coronary bypass grafting and for coronary disease prevention.
Parsons, W. (2001) · Circulation · doi:10.1161/01.cir.104.2.e7 · Cited by 1
Obesity, low for gestational age birth weight, and subsequent cardiovascular risk
Luft, F. C. (2001) · Journal of molecular medicine · doi:10.1007/s001090100208 · Cited by 1
Aspirin for primary prevention: Consider ‘the risk’
Ritchie, L., Lowe, G. D. O., Loke, Y. K., Fletcher, K., & Begg, A. G. (2001) · Coronary Health Care · doi:10.1054/chec.2001.0113
Hypertriglyceridemic waist phenotype in older adults: prevalence and associated factors
de Souza, Y. S., dos Santos, L., da Silva, D. J., Barbosa, R. D. S., Pinto, L. L. T., Valença, P. D. F., & Casotti, C. A. (2024) · Cadernos Saúde Coletiva · doi:10.1590/1414-462x202432040610 · Cited by 1
“This combination defines the hypertriglyceridemic waist (HW) phenotype 3 , an adverse health condition in older adults that increases the likelihood of cardiovascular diseases and raises mortality risk 4,5 .”
Cardiovascular risk reduction and aerobic exercise in firefighters.
Miramontes, N., Diaz, D., & Lourdes, M. (2015) · Nutrición clínica y dietética hospitalaria · doi:10.12873/351navarrete · Cited by 1
Cardiometabolic Risk Factors and the Metabolic Syndrome
Sakr, M., & Hamdy, O. (2015) · The Endocrine Society eBooks · doi:10.1210/mn1.9781936704842.ch14 · Cited by 1
Després, J. (2013) · Springer eBooks · doi:10.1007/978-1-4471-2834-2_16 · Cited by 1
Self-citationComprehensive Lipid Profiling Beyond LDL
Arsenault, B., Boekholdt, S., Kastelein, J., & Despres, J. (2011) · Humana Press eBooks · doi:10.1007/978-1-60327-179-0_8 · Cited by 1
Self-citationDrug Treatment in the Metabolic Syndrome
Karathanasis, S. K., & SCHIEBINGER, R. J. (2005) · Elsevier eBooks · doi:10.1016/b978-84-8174-892-5.50027-9 · Cited by 1
Paquin, A., Prémont, C., Mathieu, M., Lê-Brassard, M., Gigleux, I., Neyron, A., Lemieux, S., Clavel, M., Ross, R., Després, J., et al. (2026) · Metabolic Syndrome and Related Disorders · doi:10.1177/15578518261500227
Self-citationLi, X.-Q., Peng, J., Quan, J.-J., Zhang, D.-D., Chen, L., Liu, M.-Q., Zhang, Y., Yi, B., & Huang, Z.-J. (2026) · Diabetes, obesity and metabolism · doi:10.1111/dom.71427
Gažarová, M., Lenártová, P., Žemberyová, J., Civáňová, L., Hačková, L., Kijovská, M., Šubová, L., & Górnicka, M. (2026) · Metabolites · doi:10.3390/metabo16080567
“…syndrome, waist circumference, either alone or in combination with elevated triglyceride concentrations as the hypertriglyceridemic waist phenotype, has emerged as a clinically useful surrogate marker of visceral fat accumulation and a robust predictor of increased cardiometabolic risk [9–11].”
Rethinking cardiometabolic risk: The role of childhood neglect and biomarker decoupling
Jopling, E. N., Mens, M. M. J., Hare, M. M., Drury, S. S., Fox, N. A., Nelson, C. A., Zeanah, C. H., & Slopen, N. B. (2026) · Annals of Epidemiology · doi:10.1016/j.annepidem.2026.110201
Phosphomannomutase 1 restrains adipose thermogenic programming via inosine signaling
Ye, Y., Xu, R., Liu, T., Su, Y., Lu, X., Sun, J., Zhao, J., Lu, Y., Yang, Y., & Han, J. (2026) · Molecular Metabolism · doi:10.1016/j.molmet.2026.102386
“Accordingly, comprehensive assessments employ additional measures such as waist circumference and waist-to-hip ratio, alongside biochemical markers like triglycerides [34 — 36].”
Minu, T., Varghese, J., Kompithra, R., Sudeep, K., & Abraham, J. (2026) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_456_25
Cândido, F., da Silva, A., Oliveira, N. M. C. E., Zanirate, G. A., & Hermsdorff, H. H. M. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112341
Yang, Z., Ng, J., Fung, W., Chan, G., Chow, K.-M., & Szeto, C. (2025) · Journal of Nutrition and Metabolism · doi:10.1155/jnme/8007869
“Te simultaneous presence of increased waist girth and fasting triglyceride levels is a common abnormality detected in MS, referred to as ‘hypertriglyceridemic waist’ [40].”
Kamarudin, S. P., Samsudin, E. Z., Ismail, Z., Ibrahim, K., Bukhary, N., & Suddin, L. (2023) · International Journal of Membrane Science and Technology · doi:10.15379/ijmst.v10i2.2701
“They used a cut-off point of TG ≥2.0 mmol/L for serum TG and waist circumference (WC) ≥90 cm for their male subjects [17].”
InfluentialMetabolic Syndrome in Patients of a Psychosocial Care Center in Brazil: A Cross-Sectional Study
Silva, D. A. R., de Almeida, L. S., Correa, L. L., Pimentel, R., Gomes, A. T., Travassos, A. G., Viana, A. M., Cerqueira, M., de Souza, M. C., de Sousa, A. D., et al. (2021) · doi:10.20944/preprints202111.0554.v1
“It was first described by Lemieux in 2000 [13].”
BackgroundKumar, K., Raj, R., & Sattar, F. (2020) · Telangana Journal of Psychiatry · doi:10.18231/j.tjp.2020.007
Hypertriglyceridaemic waist phenotype for Chronic Kidney Disease population: NEFRONA cohort.
Bielsa-Gracia, S., Lou, L. M., Gimeno, J., Gracia-García, O., López-Alejaldre, I., & Fernández, E. (2020) · Nefrología · doi:10.1016/j.nefro.2019.12.005
Hypertriglyceridaemic waist phenotype for Chronic Kidney Disease population: NEFRONA cohort
Bielsa-Gracia, S., Lou, L., Gimeno, J. A., Gracia-García, O., López-Alejaldre, I., & Fernández, E. (2020) · Nefrología (English Edition) · doi:10.1016/j.nefroe.2019.12.007
Prevalence And Factors Associated With Hypertriglyceridemic Waist In Colombian Elderly.Preprint
Rincón-Pabón, D., Urazán-Hernández, Y., Gómez-Rodas, A., & Martínez-Torres, J. (2019) · Research Square · doi:10.21203/rs.2.12972/v1
“Dependent variables The HTGW phenotype was defined as the outcome variable(16), those people who presented with abdominal obesity (the cut points used were abdominal circumference> 80 cm for women and> 90 cm for men (17)) and hypertriglyceridemia (cut-off point used was triglycerides ≥ 150 mg / dl (16)).”
MethodSargowo, D., Purwanto, E. F., Nugroho, F., Kamila, P., Irawan, D., Sitio, M., Adrian, L., Pratama, A. R., Arifin, Y., Fadlan, M. R., et al. (2019) · INTERNATIONAL CONFERENCE ON BIOINFORMATICS AND NANO-MEDICINE FROM NATURAL RESOURCES FOR BIOMEDICAL RESEARCH: 3rd Annual Scientific Meeting for Biomedical Sciences · doi:10.1063/1.5110002
Identifying and Treating the Metabolic Syndrome
Andrew, C. A. (2018) · Springer eBooks · doi:10.1007/978-3-030-01039-3_1
Sangaleti, C. T. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2017.tde-19062017-151724
Study of Oxidative Stress Marker Serum Paraoxonase in Metabolic Syndrome
Metab, T. J. E., Rojekar, M., Mogarekar, M., & Adhe-Rojekar, A. (2016) · Endocrinology research and practice. · doi:10.4274/tjem.3586
Khan, S., Bokhari, S. A. R., & Hanif, M. (2016) · The Professional Medical Journal · doi:10.17957/tpmj/16.3400
Hypertriglyceridemic waist in hypertensive patients
Mota, A. P., Machado, M. E. P. D. C., Almeida, M., da Silva, M. D., de Mattos, D. B., Oliveira, T. L., & Medeiros, J. B. (2016) · doi:10.5935/2359-4802.20160036
INDEKS LINGKAR PINGGANG-TRIGLISERIDA PADA REMAJA PUTRI STUNTED OBESITY DI PEDESAAN JEPARA
Sari, P., & Sulchan, M. (2016) · doi:10.14710/jnc.v5i3.16406
“29,30 Trigliserida adalah penyebab utama patogenesis dari aterosklerosis dan merupakan faktor risiko untuk coronary heart disease (CHD).(31) Trigliserida menyebabkan peningkatan LDL dan penurunan HDL-C, dan metabolit lipoprotein tinggi trigliserida yang langsung menyebabkan aterosklerosis.”
BackgroundJONAFES 2014 - Ciências Exatas, Humanas, Sociais, Biológicas e da Saúde
Claros, J. (2016) · Motricidade · doi:10.6063/motricidade.6978
Hemostatic risk marker associated with cardiovascular events in metabolic syndrome
Bodanese, L., Wiehe, M., Jardim, J., Bonato, C., & Munhoz, E. (2015) · International Journal of Cardiovascular Sciences · doi:10.5935/2359-4802.20150020
Optimal Adiposity Measurement and Risk Stratification in Established Ischaemic Stroke
Lennon, O., & Blake, C. (2014) · World Journal of Cardiovascular Diseases · doi:10.4236/wjcd.2014.413077
Barrientos‐Alvarado, C., Vázquez, J. S., Oscoy, M. A. S. C., Garrido-Acosta, O., & Anguiano‐Robledo, L. (2014) · Revista de Nutrição · doi:10.1590/1415-52732014000600004
Approaches to Reducing Abdominal Obesity
Li, Z.-P., & Heber, D. (2014) · doi:10.1201/b16661-17
Fonction ventilatoire, asthme et facteurs de risque cardiométabolique
Léone, N. (2014) · theses.fr (ABES) · doi:10.70675/47a1f349zed58z4a1cz9119z36e40df00f6e
Vallecillo-Sánchez, G. (2012) · Medicina clínica (Ed. impresa) · doi:10.1016/j.medcli.2012.06.020
Il "Progetto Bagnacavallo": prevalenza dell'ipertransaminasemia e NAFLD nella popolazione generale
Savini, S. (2012) · AMS Dottorato Institutional Doctoral Theses Repository (University of Bologna) · doi:10.6092/unibo/amsdottorato/4362
Association Between the Hypertriglyceridemic-Waist Phenotype in Mothers and in Their Offspring
Hirschler, V. (2011) · InTech eBooks · doi:10.5772/22287
Screening for diabetes in a local population of Patan, Nepal
Br, M., Shakya, P., & Bhandary, S. (2010) · Journal of General Practice and Emergency Medicine of Nepal · doi:10.59284/jgpeman202
非糖尿病健常日本人における,肥満と代謝性危険因子との間の年齢別,性別相関関係の特徴:肥満と空腹時血糖との相関は50歳以下では男性よりも女性で強い
小田, 栄., & 隆, 河. (2010) · Ningen dock : official journal of the Japanese Society of Human Dry Dock · doi:10.11320/ningendock.24.1024
Oda, E., & Kawai, R. (2010) · Ningen dock : official journal of the Japanese Society of Human Dry Dock · doi:10.11320/ningendock.24.43
Fat of the matter: inflammation, the waist and cardiovascular risk
Devaraj, S., & Jialal, I. (2009) · Clinical Lipidology · doi:10.2217/clp.09.46
Abdominal Obesity, Metabolic Syndrome, and Risk of Cardiovascular Disease
Marzo, J. (2008) · CRC Press eBooks · doi:10.3109/9781420060850-5
AlFaris, N. A. (2008) · Egyptian Journal of Agricultural Sciences /Egyptian Journal of Agricultural Sciences · doi:10.21608/ejarc.2008.217271
Bruckert, E., & Baccara-Dinet, M. (2007) · Current Medical Research and Opinion · doi:10.1185/030079907x225439
“2006 Physicians’ perceptions of obesity © 2007 LiBrApHArM Ltd – Curr Med res Opin 2007; 23(8) obesity and low HDL-cholesterol are included within the diagnostic criteria for the metabolic syndrome according to the US National Cholesterol Education Program/Adult Treatment Panel III (NCEP/ATPIII)(10) and the Internation…”
BackgroundMethodPolycystic ovary syndrome and metabolic syndrome
Hayden, C. J., & Balen, A. H. (2006) · Expert Review of Obstetrics & Gynecology · doi:10.1586/17474108.1.2.183
Metadata
- Authors
- Lemieux, I., Pascot, A., Couillard, C., Lamarche, B., Tchernof, A., Alméras, N., Bergeron, J., Gaudet, D., Tremblay, G., Prud’homme, D., Nadeau, A., & Després, J.-P.
- Affiliations
- Centre hospitalier de l'Université Laval (CA)
- From the Quebec Heart Institute, Laval Hospital Research Center; the Lipid Research Center, CHUL Research Center; the Physical Activity Sciences Laboratory, Laval University; the Diabetes Research Unit, CHUL Research Center, Ste-Foy; and the Lipid Clinic, Chicoutimi Hospital, Chicoutimi, Québec, Canada.
- ORCID
- Venue
- Circulation
- Published
- 2000-07-11
- Volume
- 102
- Issue
- 2
- Pages
- 179-184
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1991251155
- Cited by
- 937
- References
- 0
- Citations by year
- 2026: 10 · 2025: 19 · 2024: 23 · 2023: 28 · 2022: 31 · 2021: 29 · 2020: 30 · 2019: 26 · 2018: 35 · 2017: 29 · 2016: 38 · 2015: 38 · 2014: 42 · 2013: 42 · 2012: 49
- FWCI
- 18.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Heart Association
- Heart and Stroke Foundation of Canada
- Medical Research Council Canada
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Keywords
- hypertriglyceridemic waist phenotype, waist circumference, fasting plasma triglycerides, hyperinsulinemia, apolipoprotein B, small dense LDL, coronary artery disease risk, cardiovascular screening, men
- MeSH terms
- Abdomen, Adult, Apolipoproteins B, Body Composition, Coronary Artery Disease, Coronary Disease, Humans, Hyperinsulinism, Lipoproteins, LDL, Male, Mass Screening, Middle Aged, Predictive Value of Tests, Risk Factors, Triglycerides, Hypertriglyceridemia, Biomarkers, Coronary Angiography
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review